- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | ANAGENICS LIMITED: York Street Brands Product Launch | - | ASX | ||
| 22.05. | ANAGENICS LIMITED: Correction of Appendix 3Y lodged on 21 May 2025 | - | ASX | ||
| 21.05. | ANAGENICS LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 14.05. | ANAGENICS LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 08.05. | ANAGENICS LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 06.05. | ANAGENICS LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 05.05. | ANAGENICS LIMITED: AN1 - 3Q25 Presentation | - | ASX | ||
| ANAGENICS Aktie jetzt für 0€ handeln | |||||
| 02.05. | ANAGENICS LIMITED: Reinstatement to Quotation | - | ASX | ||
| 02.05. | ANAGENICS LIMITED: AN1 - Pre-reinstatement Disclosure | - | ASX | ||
| 02.05. | ANAGENICS LIMITED: AN1 - Appendix 4G and CGS (June 2024) - final | - | ASX | ||
| 01.05. | ANAGENICS LIMITED: AN1 3Q25 Activity Report | - | ASX | ||
| 01.05. | ANAGENICS LIMITED: Appendix 4C Cash Flow Report | - | ASX | ||
| 17.04. | ANAGENICS LIMITED: Change in substantial holding from HNG | - | ASX | ||
| 10.04. | ANAGENICS LIMITED: Becoming a substantial holder | - | ASX | ||
| 09.04. | ANAGENICS LIMITED: Long Term Suspended Entities | - | ASX | ||
| 08.04. | ANAGENICS LIMITED: Notification of cessation of securities - AN1 | - | ASX | ||
| 08.04. | ANAGENICS LIMITED: Notification of cessation of securities - AN1 | - | ASX | ||
| 08.04. | ANAGENICS LIMITED: Notification of cessation of securities - AN1 | 1 | ASX | ||
| 08.04. | ANAGENICS LIMITED: Notification of cessation of securities - AN1 | - | ASX | ||
| 08.04. | ANAGENICS LIMITED: Notification of cessation of securities - AN1 | - | ASX |
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 65,55 | +2,49 % | Novo Nordisk stark: Gelingt jetzt der Ausbruch? | Die Aktie von Novo Nordisk hat sich in den vergangenen Monaten alles andere als gut entwickelt. Mehr als 60 Prozent hat das Papier seit Juli vergangenen Jahres an Wert eingebüßt. Nun scheint sich aber... ► Artikel lesen | |
| AURORA CANNABIS | 5,030 | +0,20 % | Aurora Cannabis Inc (3): Aurora Cannabis launches IndiMed Tempo 22 | ||
| CANOPY GROWTH | 1,498 | +0,67 % | Canopy Growth has price target chopped at Roth | ||
| TILRAY BRANDS | 0,357 | +0,11 % | Tilray Brands Inc: Tilray Brands to be deleted from S&P/TSX Composite | ||
| VERTEX PHARMACEUTICALS | 395,50 | +0,08 % | Vertex Pharmaceuticals Incorporated: Vertex Presents New Data on Benefits of ALYFTREK and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference | - Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with... ► Artikel lesen | |
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT clarifies disclosure about Premium Products buy | ||
| ARZNEIWERK AG VIDA | 0,695 | +10,32 % | PTA-AFR: Arzneiwerk AG VIDA: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG | DJ PTA-AFR: Arzneiwerk AG VIDA: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG
Vorabbekanntmachung Finanzberichte gemäß ---- 114-117 WpHG
Arzneiwerk... ► Artikel lesen | |
| CRONOS GROUP | 1,728 | -0,80 % | Cronos Group Inc.: Cronos Group Reports 2025 First Quarter Results | Net revenue in Q1 2025 increased by 28% year-over-year, 33% year-over-year net revenue growth on a constant currency basis PEACE NATURALS® retained its position as the number one cannabis brand in... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Provides Update Regarding Proposed RTO Transaction | / Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. ("Digicann" or... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,170 | -1,68 % | Organigram Global Inc. reicht 6-K Bericht bei der SEC ein | ||
| IONIS PHARMACEUTICALS | 30,650 | +0,46 % | Ionis Pharmaceuticals, Inc.: Ionis expands partnership with Sobi to include olezarsen commercialization outside the U.S. | - Agreement enables olezarsen to reach people living with conditions associated with elevated triglycerides across the world - - Ionis will continue to independently commercialize TRYNGOLZA (olezarsen)... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 4,600 | +0,97 % | Green Thumb Industries Inc: Green Thumb to hold cannabis, music festival | ||
| MYDECINE INNOVATIONS GROUP | 0,002 | -80,00 % | Aquis Stock Exchange: Withdrawal from Trading - Mydecine Innovations Group Inc. | Aquis Stock Exchange
Aquis Stock Exchange: Withdrawal from Trading 02-Apr-2025 / 07:00 GMT/BST
The issuer is solely responsible for the content of this... ► Artikel lesen | |
| SANTHERA PHARMACEUTICALS | 13,980 | -5,41 % | Santhera Pharmaceuticals Holding AG: Santheras Aktionäre stimmen an der heutigen Generalversammlung allen Anträgen des Verwaltungsrats zu | Pratteln, Schweiz, 20. Mai 2025 - Santhera Pharmaceuticals (SIX: SANN) gibt heute bekannt, dass die Aktionäre an der heutigen Generalversammlung (GV) in Pratteln, Schweiz, allen Anträgen des Verwaltungsrates... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 36,000 | +1,12 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction | Investigator-initiated Phase 2 trial to evaluate TNX-102 SL's potential to reduce severity of acute stress reaction (ASR) and frequency of acute stress disorder (ASD) Trial is sponsored by the University... ► Artikel lesen |
Das Unternehmen ANAGENICS LIMITED kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ANAGENICS LIMITED finden Sie auf Wallstreet Online.